Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin

A d-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization

(2014) Donna M. Veine et al.   CLINICAL & EXPERIMENTAL METASTASIS

α5β1 Integrin Ligand PHSRN Induces Invasion and α5 mRNA in Endothelial Cells to Stimulate Angiogenesis

(2014) Zhao-Zhu Zeng et al.   Translational Oncology

Role of α5β1 Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells

(2014) Hongren Yao et al.   Translational Oncology

At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone

(2012) John Foley et al.   Odontology

The changing role of axillary lymph node dissection for breast cancer

(2012) Masakuni Noguchi et al.   Breast Cancer

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

(2011) David H. Henry et al.   JOURNAL OF CLINICAL ONCOLOGY

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

(2011) Karim Fizazi et al.   LANCET

Influence of stress on extracellular matrix and integrin biology

(2011) C Jean et al.   ONCOGENE

The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation

(2010) Hongren Yao et al.   BREAST CANCER RESEARCH AND TREATMENT

Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation

(2010) Hongren Yao et al.   CLINICAL & EXPERIMENTAL METASTASIS

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

(2010) Alison T. Stopeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesisviathe HIF-1α/VEGF signaling pathways in human breast cancer cells

(2009) Xudong Tang et al.   INTERNATIONAL JOURNAL OF CANCER

Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis

(2009) M Petersen et al.   ONCOGENE

Matrix Metalloproteinase-1 and Thrombin Differentially Activate Gene Expression in Endothelial Cells via PAR-1 and Promote Angiogenesis

(2008) Jessica S. Blackburn et al.   AMERICAN JOURNAL OF PATHOLOGY

Systemic Spread Is an Early Step in Breast Cancer

(2008) Yves Hüsemann et al.   CANCER CELL

Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth

(2008) F. Donate et al.   CLINICAL CANCER RESEARCH

Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2

(2008) Verónica Alonso et al.   JOURNAL OF CELLULAR PHYSIOLOGY